| 1 |
Wang Y, Yuan A, Wu Y, Wu L, Zhang L. Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations. Journal of Functional Foods 2023;100:105384. [DOI: 10.1016/j.jff.2022.105384] [Reference Citation Analysis]
|
| 2 |
Cao Q, Ai XQ, Mushajiang M. Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis. Breast Cancer (Dove Med Press) 2023;15:175-88. [PMID: 36923396 DOI: 10.2147/BCTT.S399994] [Reference Citation Analysis]
|
| 3 |
Jampilek J, Kralova K. Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems. Pharmaceutics 2022;14. [PMID: 36559176 DOI: 10.3390/pharmaceutics14122681] [Reference Citation Analysis]
|
| 4 |
Singh J, Gautam DNS, Sourav S, Sharma R. Role of Moringa oleifera Lam. in cancer: Phytochemistry and pharmacological insights. Food Frontiers 2022. [DOI: 10.1002/fft2.181] [Reference Citation Analysis]
|
| 5 |
Zhang W, Li S, Li C, Li T, Huang Y. Remodeling tumor microenvironment with natural products to overcome drug resistance. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1051998] [Reference Citation Analysis]
|
| 6 |
Zhao P, Chen W, Feng Z, Liu Y, Liu P, Xie Y, Yu DG. Electrospun Nanofibers for Periodontal Treatment: A Recent Progress. Int J Nanomedicine 2022;17:4137-62. [PMID: 36118177 DOI: 10.2147/IJN.S370340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Ayana G, Ryu J, Choe SW. Ultrasound-Responsive Nanocarriers for Breast Cancer Chemotherapy. Micromachines (Basel) 2022;13:1508. [PMID: 36144131 DOI: 10.3390/mi13091508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Vieira IRS, Conte-Junior CA. Nano-delivery systems for food bioactive compounds in cancer: prevention, therapy, and clinical applications. Crit Rev Food Sci Nutr 2022;:1-26. [PMID: 35938315 DOI: 10.1080/10408398.2022.2106471] [Reference Citation Analysis]
|
| 9 |
Karimi Z, Taymouri S, Minaiyan M, Mirian M. Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model. Int J Pharm 2022;624:122036. [PMID: 35868480 DOI: 10.1016/j.ijpharm.2022.122036] [Reference Citation Analysis]
|
| 10 |
Stringaro A, Serra S, Gori A, Calcabrini A, Colone M, Dupuis ML, Spadaro F, Cecchetti S, Vitali A. Peptide-Mediated Targeted Delivery of Aloe-Emodin as Anticancer Drug. Molecules 2022;27:4615. [DOI: 10.3390/molecules27144615] [Reference Citation Analysis]
|
| 11 |
Shawki MM, El Sadieque A, Elabd S, Moustafa ME. Synergetic Effect of Tumor Treating Fields and Zinc Oxide Nanoparticles on Cell Apoptosis and Genotoxicity of Three Different Human Cancer Cell Lines. Molecules 2022;27:4384. [PMID: 35889257 DOI: 10.3390/molecules27144384] [Reference Citation Analysis]
|
| 12 |
Naeem M, Iqbal MO, Khan H, Ahmed MM, Farooq M, Aadil MM, Jamaludin MI, Hazafa A, Tsai WC. A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer. Molecules 2022;27:3412. [PMID: 35684353 DOI: 10.3390/molecules27113412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Sargazi S, Laraib U, Er S, Rahdar A, Hassanisaadi M, Zafar MN, Díez-pascual AM, Bilal M. Application of Green Gold Nanoparticles in Cancer Therapy and Diagnosis. Nanomaterials 2022;12:1102. [DOI: 10.3390/nano12071102] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 14 |
Mustafa NH, Sekar M, Fuloria S, Begum MY, Gan SH, Rani NNIM, Ravi S, Chidambaram K, Subramaniyan V, Sathasivam KV, Jeyabalan S, Uthirapathy S, Ponnusankar S, Lum PT, Bhalla V, Fuloria NK. Chemistry, Biosynthesis and Pharmacology of Sarsasapogenin: A Potential Natural Steroid Molecule for New Drug Design, Development and Therapy. Molecules 2022;27:2032. [PMID: 35335393 DOI: 10.3390/molecules27062032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Khattulanuar FS, Sekar M, Fuloria S, Gan SH, Rani NNIM, Ravi S, Chidambaram K, Begum MY, Azad AK, Jeyabalan S, Dhiravidamani A, Thangavelu L, Lum PT, Subramaniyan V, Wu YS, Sathasivam KV, Fuloria NK. Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders. Molecules 2022;27:673. [PMID: 35163934 DOI: 10.3390/molecules27030673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
